Avery Dennison vs Mativ
AVY and MATV side by side, both in paper and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVY and MATV compare
Avery Dennison is the larger company, worth 22 times as much as Mativ ($13.8B against $626M).
On earnings, Mativ is cheaper: it trades at 7.0× trailing earnings, against 20.0× for Avery Dennison.
Avery Dennison grew revenue faster over the last twelve months (5.8% versus 1.1% for Mativ).
Avery Dennison keeps more of each dollar of sales as profit, with a net margin of 7.6% compared with 4.5% at Mativ.
Both pay dividends: Avery Dennison yields 2.1% and Mativ 3.5%.
Mativ scores higher on the StockData Score (15 against 14 for Avery Dennison), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVY | MATV |
|---|---|---|
| Size and price | ||
| Market cap | $13.8B | $626M |
| Share price | $182.22 | $11.34 |
| Change, 1 year | 3.4% | 4.1% |
| Change, 5 years | −19.5% | −66.9% |
| Beta (5Y) | 0.76 | 1.20 |
| Employees | 25K | 5,000 |
| StockData Score | ||
| Total score | 14 | 15 (better) |
| Valuation score | 1 | 6 (better) |
| Growth score | 2 | 2 |
| Performance score | 4 (better) | 3 |
| Health score | 3 (better) | 1 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 20.0× | 7.0× (better) |
| P/S | 1.5× | 0.3× (better) |
| P/B | 5.9× | 1.3× (better) |
| EV/EBITDA | 11.9× | 7.4× (better) |
| P/FCF | 13.0× | 4.9× (better) |
| FCF yield | 7.7% | 20.4% (better) |
| Fair value | $147.11 | $20.84 |
| Margin of safety | −23.9% | 45.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.8% (better) | 1.1% |
| Revenue growth, 5Y average | 4.9% | 13.1% (better) |
| Net income growth (TTM) | −0.86% | – |
| EPS growth (TTM) | 2.4% | – |
| EPS growth, 5Y average | 5.9% | – |
| Profitability | ||
| Gross margin | 29.0% (better) | 19.4% |
| Operating margin | – | 3.5% |
| Net margin | 7.6% (better) | 4.5% |
| FCF margin | 11.5% (better) | 6.4% |
| Return on equity | 31.2% (better) | 20.2% |
| Return on invested capital | – | 3.9% |
| Financial health | ||
| Debt / equity | 1.58 (better) | 2.07 |
| Net debt / EBITDA | 2.38 (better) | 4.37 |
| Interest coverage | – | 1.0× |
| Current ratio | 1.13 | 1.98 (better) |
| Altman Z-score | 3.15 (better) | 1.40 |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 2.1% | 3.5% (better) |
| Payout ratio | 41.7% | 25.0% |
| Years of dividend growth | 15 (better) | 0 |
| Dividend growth, 5Y average | 9.4% (better) | −25.6% |
| Buyback yield | 3.0% | – |
| Shareholder yield | 5.1% (better) | 3.5% |
| Ownership | ||
| Held by institutions | 98.3% | 93.9% |
| Held by insiders | 0.63% | 2.3% |
| Insider net buying, 12 months | −$21.2M | – |
| Short interest, % of float | 2.6% | 2.0% |
Go deeper
- AVY stock overview
- AVY income statement
- AVY valuation and score
- MATV stock overview
- MATV income statement
- MATV valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.